9: Allogeneic hematopoietic stem cell transplantation in HIV-positive patients with malignant and non-malignant disorders
نویسندگان
چکیده
منابع مشابه
Allogeneic hematopoietic stem cell transplantation for non-malignant hematological disorders
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) from a geno-identical matched sibling (MSD) is one of the most successful therapies in patients with non-malignant hematological disorders. This study included 273 patients with severe aplastic anemia (SAA), 152 patients with B-Thalassemia major (BTM), 31 patients with Fanconi's anemia (FA), 20 patients with congenital immunodeficie...
متن کاملClinical implications of chimerism after allogeneic hematopoietic stem cell transplantation in children with non-malignant diseases
BACKGROUND The effects of chimerism on outcomes following allogeneic hematopoietic stem cell transplantation (HSCT) are unclear and may differ between diseases. We retrospectively evaluated the association between chimerism and transplant outcomes in children with nonmalignant diseases. METHODS Chimerism was evaluated using short-tandem repeat polymerase chain reaction (STR-PCR) in 48 patient...
متن کاملNew Allogeneic hematopoietic Stem Cell Transplantation Method for Treatment of Malignant Tumor: Hematopoietic Stem Cells + Thymus Transplantation
Cite this article: Hosaka N (2014) New Allogeneic–Hematopoietic Stem Cell Transplantation Method for Treatment of Malignant Tumor: Hematopoietic Stem Cells + Thymus Transplantation. Ann Clin Pathol 2(1): 1007. *Corresponding author Naoki Hosaka, Department of Pathology, Kansai Medical University Kori Hospital, 8-45 Korihondori, Neyagawa, Osaka, 572-8851, Japan, Tel: 81-72-832-5321; Fax: 81-72-8...
متن کاملPediatric Hematopoietic Stem Cell Transplantation
The introduction and evolution of hematopoietic stem cell transplantation (HSCT) could be traced back to 1950s, to the studies on interactions among irradiation, covering spleen and bone marrow from it and injection of bone marrow cells. Today, HSCT is considered a well-established, effective and promising means of therapy for various malignant and non-malignant medical conditions, both in chil...
متن کاملRelapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
Allogeneic hematopoietic cell transplantation (HCT) after nonmyeloablative conditioning for hematologic malignancies depends on graft-versus-tumor effects for eradication of cancer. Here, we estimated relapse risks according to disease characteristics. Between 1997 and 2006, 834 consecutive patients (median age, 55 years; range, 5-74 years) received related (n = 498) or unrelated (n = 336) HCT ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Biology of Blood and Marrow Transplantation
سال: 2007
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2006.12.012